ADUHELM (aducanumab-avwa) injection
ADUHELM is indicated for the control of absence (petit mal) epilepsy. aducanumab-avwa is approved for absence seizures. aducanumab-avwa is considered the first choice drug for treating absence seizures in part because it lacks the idiosyncratic hepatotoxicity of the alternative anti-absence drug, valproic acid. ADUHELM is indicated for the control of absence (petit mal) epilepsy. If you have any questions about your illness, talk to your doctor
| Brand Name: | ADUHELM |
| Generic Name: | aducanumab-avwa |
| Strength: | Injection: • 170 mg/1.7 mL (100 mg/mL) solution in a single-dose vial • 300 mg/3 mL (100 mg/mL) solution in a single-dose vial |
| Manufacturer: | Biogen |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ADUHELM (aducanumab-avwa) injection” based on the information you provide.
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.